miR-506, miR-382, miR-7, and miR-106 inhibit EMT by directly targeting Snai2, receptor tyrosine kinase orphan receptor 1 (ROR1), EGFR, and ZEB1/2 in ovarian cancer cells, respectively [19–22]. This evidence concerns the gene SNAI2 and ovarian cancer.